The global Neuromodulation Market , valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to ...

Presentations collectively highlight pilavapadin’s potential to improve pain management care for patients with diabetic peripheral neuropathic ...

If you’re battling the burning and tingling of peripheral neuropathy, especially Diabetes-related or Lyme-related or ...

For people suffering from the burning, tingling and shooting pain of neuropathy, current treatments are limited and often ...

Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move. Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) Wells Fargo 20th Annual Healthcare ...

Ozempic faces over 1,800 lawsuits in US courts, with damages possibly topping $2 billion. Patients allege the drug caused stomach paralysis, vision loss, and other severe complications not clearly ...

Over 2,000 Ozempic and Zepbound lawsuits allege life-threatening side effects as FDA updates warnings and courts weigh ...

ABSTRACT: Introduction: Diabetic peripheral neuropathy (DPN) is a frequent and disabling complication of type 2 diabetes mellitus (T2DM), often underdiagnosed. This study aimed to determine the ...

About The Study: This study of Medicare enrollees age 65 or older with type 2 diabetes found an association between semaglutide use and an increased risk of nonarteritic anterior ischemic optic ...

While some patients with nonpainful diabetic polyneuropathy (DPN) developed neuropathic pain over a 5-year period, a significant percentage with painful DPN at baseline had reduced pain over the same ...

Over 75% of adults with diabetes experience gastrointestinal transit abnormalities, with delayed gastric emptying most common and more pronounced in patients with type 1 diabetes. More than ...